Retraction notices

Efficacy And Safety Of Adalimumab Versus Infliximab In Patients Suffered From Moderate To Severe Active Ulcerative Colitis

Type
Retraction
Notice date
8/31/2021 0:00
Journal
Asian Journal of Pharmaceutical and Clinical Research
Publisher
Innovare Academic Sciences
Notice DOI
10.22159/ajpcr.2017.v10i3.16213
Original paper DOI
10.22159/ajpcr.2017.v10i3.16213

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.